In November 2019, the US Food and Drug Administration (FDA) granted psilocybin therapy a breakthrough status for depression. This recognition makes it the second time
In November 2019, the US Food and Drug Administration (FDA) granted psilocybin therapy a breakthrough status for depression. This recognition makes it the second time